Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model.

Vliegenthart ADB, Wei C, Buckley C, Berends C, de Potter CMJ, Schneemann S, Del Pozo J, Tucker C, Mullins JJ, Webb DJ, Dear JW.

Toxicol Sci. 2017 Oct 1;159(2):380-391. doi: 10.1093/toxsci/kfx144.

2.

The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122.

Rivoli L, Vliegenthart AD, de Potter CM, van Bragt JJ, Tzoumas N, Gallacher P, Farrah TE, Dhaun N, Dear JW.

Br J Clin Pharmacol. 2017 Mar;83(3):584-592. doi: 10.1111/bcp.13136. Epub 2016 Oct 21.

3.
4.

Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.

Lahorte CM, Bacher K, Burvenich I, Coene ED, Cuvelier C, De Potter C, Thierens H, Van de Wiele C, Dierckx RA, Slegers G.

J Nucl Med. 2004 Jun;45(6):1065-73.

5.

The role of heregulin-alpha as a motility factor and amphiregulin as a growth factor in wound healing.

Schelfhout VR, Coene ED, Delaey B, Waeytens AA, De Rycke L, Deleu M, De Potter CR.

J Pathol. 2002 Dec;198(4):523-33.

PMID:
12434423
6.

Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression.

De Paepe B, Verstraeten VM, De Potter CR, Bullock GR.

Histochem Cell Biol. 2002 Jan;117(1):13-9. Epub 2001 Dec 22.

PMID:
11819093
7.

Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.

De Paepe B, Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR.

Histochem Cell Biol. 2001 Sep;116(3):247-54.

PMID:
11685554
8.

Localization of BRCA1 protein at the cellular level.

De Potter CR, Coene ED, Schelfhout VR.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):423-9. Review.

PMID:
10819536
9.

Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.

Schelfhout VR, Coene ED, Delaey B, Thys S, Page DL, De Potter CR.

J Natl Cancer Inst. 2000 Apr 19;92(8):622-8.

PMID:
10772679
10.

Bilateral recurrent adult rhabdomyomas of the pharyngeal wall.

Vermeersch H, van Vugt P, Lemmerling M, Moerman M, De Potter C.

Eur Arch Otorhinolaryngol. 2000;257(1):24-6.

PMID:
10664040
11.

Single cell and tissue specific methods for evaluation of radiation and microgravity effects.

Van Oostveldt P, Vangestel S, Meesen G, Poffÿn A, Coene ED, Schelfhout VR, De Potter CR.

Mutat Res. 1999 Dec 6;430(2):235-40.

PMID:
10631338
12.

Hair removal in 40 hirsute women with an intense laser-like light source.

Schroeter CA, Raulin C, Thürlimann W, Reineke T, De Potter C, Neumann HA.

Eur J Dermatol. 1999 Jul-Aug;9(5):374-9.

PMID:
10417441
13.

Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.

Brochez V, Van Heuverswyn D, Diniz JA, De Potter CR, Van den Eeckhout EG.

Lipids. 1999 May;34(5):511-6.

PMID:
10380124
14.

[Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].

Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.

Zentralbl Gynakol. 1999;121(4):190-5. Review. German.

PMID:
10355096
15.

Osteoma cutis in pseudohypoparathyroidism.

Goeteyn V, De Potter CR, Naeyaert JM.

Dermatology. 1999;198(2):209-11.

PMID:
10325484
16.

Primary pulmonary hypertension with fatal outcome in a young woman and review of the literature.

De Backer TL, De Buyzere ML, De Potter CR, Gheeraert PJ, Clement DL.

Acta Cardiol. 1999 Feb;54(1):31-9. Review.

PMID:
10214474
17.

Early prediction of chronic lung disease by tracheal aspirate cytology in ventilated newborns.

Smets K, Schelfhout V, De Potter CR, Vanhaesebrouck P.

Eur J Pediatr. 1999 Mar;158(3):234-7.

PMID:
10094446
18.

Levels of hepatocyte growth factor/scatter factor (HGF/SF) in seminal plasma of patients with andrological diseases.

Depuydt CE, De Potter CR, Zalata A, Baekelandt E, Bosmans E, Comhaire FH.

J Androl. 1998 Mar-Apr;19(2):175-82.

19.

Chondroma of the bladder.

Pauwels CF, Van den Broecke C, Demeyer JM, De Potter CR.

Virchows Arch. 1998 Mar;432(3):299-300.

PMID:
9532011
20.

Cytogenetic and molecular analysis of cellular atypical mesoblastic nephroma.

Speleman F, van den Berg E, Dhooge C, Oosterhuis W, Redeker B, De Potter CR, Tamminga RY, Van Roy N, Mannens M.

Genes Chromosomes Cancer. 1998 Mar;21(3):265-9.

PMID:
9523204
21.

Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis.

Van Gele M, Van Roy N, Jauch A, Laureys G, Benoit Y, Schelfhout V, De Potter CR, Brock P, Uyttebroeck A, Sciot R, Schuuring E, Versteeg R, Speleman F.

Eur J Cancer. 1997 Oct;33(12):1979-82.

PMID:
9516837
22.

Jejunal arteriovenous malformation, diagnosed by angiography and treated by embolization and catheter-guided surgery: case report and review of literature.

Defreyne L, Verstraeten V, De Potter C, Pattyn P, De Vos M, Kunnen M.

Abdom Imaging. 1998 Mar-Apr;23(2):127-31. Review.

PMID:
9516497
23.

Ossified retroperitoneal malignant Schwannoma with spinal leptomeningeal metastases.

Mortelé K, Lemmerling M, Defreyne L, Speleman F, De Potter C, Van Belle S, Kunnen M.

Neuroradiology. 1998 Jan;40(1):48-50.

PMID:
9493189
24.

Monosomy 22 in a mixed germ cell-sex cord-stromal tumor of the ovary.

Speleman F, Dermaut B, De Potter CR, Van Gele M, Van Roy N, De Paepe A, Laureys G.

Genes Chromosomes Cancer. 1997 Jul;19(3):192-4.

PMID:
9219001
25.

BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus.

Coene E, Van Oostveldt P, Willems K, van Emmelo J, De Potter CR.

Nat Genet. 1997 Jun;16(2):122-4. No abstract available.

PMID:
9171821
26.

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.

Coene ED, Schelfhout V, Winkler RA, Schelfhout AM, Van Roy N, Grooteclaes M, Speleman F, De Potter CR.

Virchows Arch. 1997 May;430(5):365-72.

PMID:
9174626
27.
28.

Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects.

Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C, Prade M.

Int J Cancer. 1996 Nov 4;68(3):317-24.

29.

Multiple polysomies in nasal polyps in children.

Speleman F, De Potter C, Van Roy N, Laureys G.

Cancer Genet Cytogenet. 1996 Aug;90(1):86-7. Review.

PMID:
8780754
30.

Schwannoma of the larynx: a case report.

Ingels K, Vermeersch H, Verhoye C, De Potter C.

J Laryngol Otol. 1996 Mar;110(3):294-6. Review.

PMID:
8730376
31.

The receptor encoded by the human C-MET oncogene is expressed in testicular tissue and on human spermatozoa.

Depuydt CE, Zalata A, de Potter CR, van Emmelo J, Comhaire FH.

Mol Hum Reprod. 1996 Jan;2(1):2-8.

PMID:
9238650
32.

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast.

De Potter CR, Schelfhout AM, Verbeeck P, Lakhani SR, Brünken R, Schroeter CA, Van den Tweel JG, Schauer AJ, Sloane JP.

Hum Pathol. 1995 Jun;26(6):601-6.

PMID:
7774888
33.

[Breast calcifications].

Villeirs G, Mortier M, De Potter C, Kunnen M.

J Belge Radiol. 1995 Feb;78(1):11-7. Review. Dutch.

PMID:
7890588
34.

The neu-protein and breast cancer.

De Potter CR, Schelfhout AM.

Virchows Arch. 1995;426(2):107-15. Review.

PMID:
7757280
35.

Chondrosarcoma of the larynx. A diagnostic and therapeutic dilemma.

Vangehuchten S, Dhooge I, De Potter C, Vermeersch H, Van Cauwenberge P.

Acta Otorhinolaryngol Belg. 1995;49(1):19-23. Review.

PMID:
7725914
36.

The neu-oncogene: more than a prognostic indicator?

De Potter CR.

Hum Pathol. 1994 Dec;25(12):1264-8. Review.

PMID:
8001919
37.

Chromosome aberrations in fibrous dysplasia.

Dal Cin P, Sciot R, Speleman F, Samson I, Laureys G, de Potter C, Meire F, van Damme B, van den Berghe H.

Cancer Genet Cytogenet. 1994 Oct 15;77(2):114-7.

PMID:
7954320
38.

Bronchopneumonia caused by Propionibacterium acnes.

Claeys G, Verschraegen G, De Potter C, Cuvelier C, Pauwels R.

Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):747-9.

PMID:
7843179
39.

Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast.

de Potter CR, Eeckhout I, Schelfhout AM, Geerts ML, Roels HJ.

Histopathology. 1994 Apr;24(4):349-56.

PMID:
7519165
40.

A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.

De Corte V, De Potter C, Vandenberghe D, Van Laerebeke N, Azam M, Roels H, Mareel M, Vandekerckhove J.

J Cell Sci. 1994 Mar;107 ( Pt 3):405-16.

41.

A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion.

De Potter CR, Schelfhout AM, De Smet FH, Van Damme S, de Ridder L, Dhont E, van Emmelo J.

Am J Pathol. 1994 Jan;144(1):95-103.

42.

Adenomyoepithelioma of the breast with features of malignancy.

Pauwels C, De Potter C.

Histopathology. 1994 Jan;24(1):94-6. No abstract available.

PMID:
8144150
43.

The p185erbB2 protein is localized on cell organelles involved in cell motility.

De Potter CR, Quatacker J.

Clin Exp Metastasis. 1993 Nov;11(6):453-61.

PMID:
7900945
44.

Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.

De Potter CR, Foschini MP, Schelfhout AM, Schroeter CA, Eusebi V.

Virchows Arch A Pathol Anat Histopathol. 1993;422(5):375-80.

PMID:
8100656
45.

Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.

Verhasselt B, Van Damme J, van Larebeke N, Put W, Bracke M, De Potter C, Mareel M.

Eur J Cell Biol. 1992 Dec;59(2):449-57.

PMID:
1493810
46.

c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.

Schroeter CA, De Potter CR, Rathsmann K, Willighagen RG, Greep JC.

Br J Cancer. 1992 Oct;66(4):728-34.

47.

Measurement of short-term 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET).

van Eijkeren ME, De Schryver A, Goethals P, Poupeye E, Schelstraete K, Lemahieu I, De Potter CR.

Acta Oncol. 1992;31(5):539-43.

PMID:
1419100
48.

Small cell prostate cancer with bone marrow invasion--a case report.

Niël C, Huys J, De Potter C.

Acta Oncol. 1992;31(5):595-6. No abstract available.

PMID:
1384588
49.

New perspectives offered by combining a selective counterstaining (PTA) and postembedding lectin- or immuno-gold procedures.

Quatacker J, De Potter C, Annaert W, De Potter W, Roels H.

Prog Histochem Cytochem. 1992;26(1-4):49-52. Review. No abstract available.

PMID:
1283019
50.

Supplemental Content

Loading ...
Support Center